Quantinuum Prices 28M Shares at $60
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 hours ago
0mins
Quantinuum (QNT) priced 28M shares at $60.00. The deal size was increased to 28M shares from 26.5M and priced above the $53.00-$55.00 target range. JPMorgan and Morgan Stanley are acting as joint book running managers for the offering. Quantinuum is a quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy QNT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on QNT
Wall Street analysts forecast QNT stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 60.000
Low
Averages
High
Current: 60.000
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Quantinuum Raises $1.7 Billion in IPO Above Expected Range
- Significant Fundraising: Quantinuum raised $1.7 billion by offering 28 million shares at $60 each, exceeding the revised range of $53 to $55, indicating strong market demand for quantum computing technology.
- Offering and Pricing Adjustments: Initially planning to offer 21.1 million shares priced between $45 and $50, the company revised its offering size and price range on June 1, reflecting investor confidence in its growth potential.
- Broad Technology Applications: Focused on developing quantum computing systems and software, Quantinuum aims to commercialize quantum technology for applications in artificial intelligence, cybersecurity, drug discovery, and materials science, driving the evolution of hybrid computing.
- Market Positioning and Trading Info: Based in Broomfield, CO, Quantinuum will trade on Nasdaq under the symbol QNT, with prominent investment banks like J.P. Morgan and Morgan Stanley acting as joint bookrunners, enhancing market trust in the company.
See More
Quantinuum's IPO Marks a Milestone for Quantum Computing Sector
- Industry Milestone: Quantinuum's (QNT) successful IPO on Thursday marks a significant turning point for the quantum computing sector, with analysts calling it a “marquee public listing” that enhances the credibility of the industry.
- Market Size Expectations: The current market capitalization of the quantum computing sector stands at approximately $75 billion, with analysts projecting that it could reach multiple hundreds of billions, if not over $1 trillion, within the next five to ten years, indicating substantial growth potential.
- Revenue Outlook: Although Quantinuum's (QNT) revenue is expected to be in the “few tens of millions of dollars” for 2025, analysts emphasize that valuations in quantum computing reflect long-term potential rather than near-term fundamentals, showcasing market confidence in future prospects.
- Critical Years Ahead: Analysts identify the years 2028 to 2030 as pivotal for the industry, coinciding with the anticipated arrival of quantum advantage and accelerated commercial adoption, which will further drive industry development.
See More
Quantinuum Debuts on Nasdaq, Raises $1.68 Billion
- Market Debut: Quantinuum began trading on Nasdaq on Thursday with an opening price of $68 per share, representing a 13.3% increase over its upsized IPO price of $60, reflecting strong market interest in the quantum computing sector.
- Capital Raised: The company raised $1.68 billion through its IPO, exceeding its initial price range of $53 to $55, indicating investor confidence in its quantum computing platform and future growth potential.
- Diverse Clientele: Quantinuum serves clients across various sectors including pharmaceuticals, materials science, and finance, with notable customers like JPMorgan Chase and Amgen, showcasing the broad applicability of its technology and solidifying its market position.
- Financial Performance: Despite a 73% year-over-year revenue decline to $5.24 million in Q1 and a net loss of $136.5 million, the CEO emphasized the growing demand for quantum computing resources, suggesting a potential path to profitability in the future.
See More
Quantinuum Successfully Debuts on Nasdaq with $1.68B IPO
- Strong IPO Performance: Quantinuum opened at $68 on its Nasdaq debut, climbing 12% from its IPO price, indicating robust market demand and investor confidence in its quantum computing technology.
- Massive Fundraising: The IPO raised nearly $1.68 billion by offering 28 million shares at $60 each, propelling the company's valuation to over $15 billion, marking a significant milestone in the commercialization of quantum computing.
- High Market Demand: The stock attracted about 20 times the demand compared to shares offered, reflecting investors' high expectations for future applications of quantum technology, particularly in healthcare, cybersecurity, and energy sectors.
- Strategic Partnership Opportunities: The company signed a deal with the U.S. federal government for R&D funding to address technology bottlenecks in fault-tolerant trapped-ion quantum computers, and inked a memorandum of understanding with Mitsubishi Electric to develop quantum computing applications for advanced industrial engineering and design.
See More
Quantinuum IPO Raises $1.68 Billion, Valued at $17.6 Billion
- Strong IPO Performance: Quantinuum opened at $68 per share on Nasdaq, raising $1.68 billion and achieving a market cap of approximately $17.6 billion, reflecting robust market interest and confidence in quantum computing.
- Diverse Customer Base: The company serves clients across pharmaceuticals, materials science, and finance, including JPMorgan Chase and Amgen, indicating significant application potential for its quantum computing platform and reinforcing its market position.
- Enhanced Funding Support: The U.S. Department of Commerce announced a $100 million funding commitment to Quantinuum, recognizing its strategic asset status within the quantum ecosystem, which will aid in accelerating technology development and market expansion.
- Financial Challenges: Despite a successful IPO, the company reported a 73% year-over-year revenue decline to $5.24 million in Q1, with a net loss of $136.5 million, highlighting financial pressures and challenges amid rapid expansion.
See More
Quantinuum Raises $1.7 Billion in IPO Above Expected Range
- Significant Fundraising: Quantinuum raised $1.7 billion by offering 28 million shares at $60 each, exceeding the revised range of $53 to $55, indicating strong market demand for quantum computing technology.
- Offering and Pricing Adjustments: Initially planning to offer 21.1 million shares priced between $45 and $50, the company revised its offering size and price range on June 1, reflecting investor confidence in its growth potential.
- Broad Technology Applications: Focused on developing quantum computing systems and software, Quantinuum aims to commercialize quantum technology for applications in artificial intelligence, cybersecurity, drug discovery, and materials science, driving the evolution of hybrid computing.
- Market Positioning and Trading Info: Based in Broomfield, CO, Quantinuum will trade on Nasdaq under the symbol QNT, with prominent investment banks like J.P. Morgan and Morgan Stanley acting as joint bookrunners, enhancing market trust in the company.
See More
Quantinuum's IPO Marks a Milestone for Quantum Computing Sector
- Industry Milestone: Quantinuum's (QNT) successful IPO on Thursday marks a significant turning point for the quantum computing sector, with analysts calling it a “marquee public listing” that enhances the credibility of the industry.
- Market Size Expectations: The current market capitalization of the quantum computing sector stands at approximately $75 billion, with analysts projecting that it could reach multiple hundreds of billions, if not over $1 trillion, within the next five to ten years, indicating substantial growth potential.
- Revenue Outlook: Although Quantinuum's (QNT) revenue is expected to be in the “few tens of millions of dollars” for 2025, analysts emphasize that valuations in quantum computing reflect long-term potential rather than near-term fundamentals, showcasing market confidence in future prospects.
- Critical Years Ahead: Analysts identify the years 2028 to 2030 as pivotal for the industry, coinciding with the anticipated arrival of quantum advantage and accelerated commercial adoption, which will further drive industry development.
See More
Quantinuum Debuts on Nasdaq, Raises $1.68 Billion
- Market Debut: Quantinuum began trading on Nasdaq on Thursday with an opening price of $68 per share, representing a 13.3% increase over its upsized IPO price of $60, reflecting strong market interest in the quantum computing sector.
- Capital Raised: The company raised $1.68 billion through its IPO, exceeding its initial price range of $53 to $55, indicating investor confidence in its quantum computing platform and future growth potential.
- Diverse Clientele: Quantinuum serves clients across various sectors including pharmaceuticals, materials science, and finance, with notable customers like JPMorgan Chase and Amgen, showcasing the broad applicability of its technology and solidifying its market position.
- Financial Performance: Despite a 73% year-over-year revenue decline to $5.24 million in Q1 and a net loss of $136.5 million, the CEO emphasized the growing demand for quantum computing resources, suggesting a potential path to profitability in the future.
See More
Quantinuum Successfully Debuts on Nasdaq with $1.68B IPO
- Strong IPO Performance: Quantinuum opened at $68 on its Nasdaq debut, climbing 12% from its IPO price, indicating robust market demand and investor confidence in its quantum computing technology.
- Massive Fundraising: The IPO raised nearly $1.68 billion by offering 28 million shares at $60 each, propelling the company's valuation to over $15 billion, marking a significant milestone in the commercialization of quantum computing.
- High Market Demand: The stock attracted about 20 times the demand compared to shares offered, reflecting investors' high expectations for future applications of quantum technology, particularly in healthcare, cybersecurity, and energy sectors.
- Strategic Partnership Opportunities: The company signed a deal with the U.S. federal government for R&D funding to address technology bottlenecks in fault-tolerant trapped-ion quantum computers, and inked a memorandum of understanding with Mitsubishi Electric to develop quantum computing applications for advanced industrial engineering and design.
See More
Quantinuum IPO Raises $1.68 Billion, Valued at $17.6 Billion
- Strong IPO Performance: Quantinuum opened at $68 per share on Nasdaq, raising $1.68 billion and achieving a market cap of approximately $17.6 billion, reflecting robust market interest and confidence in quantum computing.
- Diverse Customer Base: The company serves clients across pharmaceuticals, materials science, and finance, including JPMorgan Chase and Amgen, indicating significant application potential for its quantum computing platform and reinforcing its market position.
- Enhanced Funding Support: The U.S. Department of Commerce announced a $100 million funding commitment to Quantinuum, recognizing its strategic asset status within the quantum ecosystem, which will aid in accelerating technology development and market expansion.
- Financial Challenges: Despite a successful IPO, the company reported a 73% year-over-year revenue decline to $5.24 million in Q1, with a net loss of $136.5 million, highlighting financial pressures and challenges amid rapid expansion.
See More
